Adicet Bio, Inc Employee Directory
Biotechnology ResearchCalifornia, United States51-200 Employees
Adicet Bio, Inc. is a clinical-stage biotechnology company focused on discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The firm is building an off-the-shelf platform of gamma delta T cells that are engineered to express chimeric antigen receptors, aiming to deliver durable activity in patients. These therapies are designed to help patients afflicted by autoimmune conditions and cancer. Based in Redwood City, California, Adicet operates in the biotechnology research arena and trades on Nasdaq under the ACET ticker. In 2025, the company announced a collaboration with MaxCyte to advance the development of off-the-shelf T-cell therapies.